(97 days)
The Medtronic Attain Select™ II model 6248DEL delivery catheter system is indicated for the delivery of contrast medium and transvenous devices to the coronary sinus and left heart venous anatomy. The delivery catheter system is indicated for use with outer catheters.
The Attain Select™ II 6248DEL Delivery Catheter System contains a delivery catheter and an inner catheter. The Delivery Catheter System is used in conjunction with a commercially available Medtronic Attain outer guide catheter. The outer guide catheter is used to gain coronary sinus access. Together, all three catheters function as a telescoping system that can provide additional sub-selecting capabilities. The 6248DEL Delivery Catheter System is available in two models each containing a straight inner catheter and a delivery catheter with either a 90° or 130° curved tip. The inner catheter in both kits is identical
This document is a 510(k) summary for the Medtronic Attain Select™ II 6248DEL Delivery Catheter System. It describes the device, its intended use, and substantial equivalence to predicate devices. It also briefly mentions testing performed.
However, the provided text does not contain detailed information about specific acceptance criteria or the results of a study that quantifies compliance with those criteria for an AI/ML device.
The document states:
- "Device integrity testing was performed to support the equivalency of the Attain Select™ II 6248DEL Delivery Catheter System to the predicate devices. Testing included mechanical, functional, and biocompatibility testing. The Attain Select™ II 6248DEL Delivery Catheter System met all specified design and performance requirements."
This is a general statement that the device met its design and performance requirements, but it does not provide:
- A table of specific acceptance criteria.
- Reported device performance against those criteria in a quantitative manner.
- Details on sample size, data provenance, ground truth establishment, expert qualifications, or adjudication methods for any study results directly applicable to acceptance criteria.
- Any mention of AI, machine learning, or algorithms, let alone standalone performance or MRMC studies.
Therefore, I cannot provide the requested information from the given text because it is a submission for a delivery catheter system, not an AI/ML diagnostic device, and it does not detail specific acceptance criteria or performance study results in the manner you've requested. The document focuses on demonstrating substantial equivalence to predicate physical medical devices rather than the performance metrics of an algorithm.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the Medtronic logo. The logo consists of a circular graphic on the left and the word "Medtronic" in bold, black letters on the right. The graphic appears to depict a human figure in motion, possibly related to medical or health-related activities.
MAR 16 2006
page 1 of 2
| 510(k) SUMMARY OF SUBSTANTIAL EQUIVALENCE |
|---|
| ------------------------------------------- |
| Date Prepared: | December 7, 2005 |
|---|---|
| Applicant: | Medtronic IrelandParkmore Business Park WestGalwayIreland |
| Submission Correspondent: | Michelle NivalaRegulatory Affairs SpecialistMedtronic, Inc.1015 Gramsie RoadShoreviewMN 55126-3082USA |
| Telephone: | (763) 505 7863 |
| Fax: | (763) 505 7877 |
| michelle.nivala@medtronic.com | |
| Proprietary Name: | Attain Select™ II 6248DEL Delivery CatheterSystem |
| Common Name: | Catheter, Percutaneous |
| Device Classification: | Class II, 21 CFR 870.1250 |
| Product Code: | DQY |
Device Description
The Attain Select™ II 6248DEL Delivery Catheter System contains a delivery catheter and an inner catheter. The Delivery Catheter System is used in conjunction with a commercially available Medtronic Attain outer guide catheter. The outer guide catheter is used to gain coronary sinus access. Together, all three catheters function as a telescoping system that can provide additional sub-selecting capabilities. The 6248DEL Delivery Catheter System is available in two models each containing a straight inner catheter and a delivery catheter with either a 90° or 130° curved tip. The inner catheter in both kits is identical
{1}------------------------------------------------
Image /page/1/Picture/0 description: The image shows the Medtronic logo. The logo consists of a circular symbol on the left and the word "Medtronic" on the right. The circular symbol contains a stylized image of a person in motion. The word "Medtronic" is written in a bold, sans-serif font.
053431
page 2 of 2
Indications for Use
The Medtronic Attain Select™ II model 6248DEL delivery catheter system is indicated for the delivery of contrast medium and transvenous devices to the coronary sinus and left heart venous anatomy. The delivery catheter system is indicated for use with outer catheters.
Substantially Equivalent Devices:
The Attain Select™ 6238TEL Guide Catheter Set for Left-Heart Delivery uses similar technology and has similar intended uses, function, materials and method of operation to the following predicate devices:
- Medtronic Attain™ Access 6218A Left Heart Delivery System (K#021589, May . 30, 2002)
- Medtronic Attain™ Select™ Guide Catheter Set for Left-Heart Delivery . (K#042194, cleared September 15, 2004)
- Guidant RAPIDO™ Cut-Away Guiding Catheter (K#031505, cleared June 25, ● 2003)
Summary of Studies:
Device integrity testing was performed to support the equivalency of the Attain Select™ II 6248DEL Delivery Catheter System to the predicate devices. Testing included mechanical, functional, and biocompatibility testing. The Attain Select™ II 6248DEL Delivery Catheter System met all specified design and performance requirements.
Biocompatibility Information
Medtronic has tested the materials used to fabricate the Attain Select™ II 6248DEL Delivery Catheter System for biocompatibility. The testing performed by Medtronic is consistent with International Standard ISO 10993-1: 2003, "Biological Evaluation of Medical devices- Part 1: Evaluation and Testing." When classified according to this standard, the catheters included in the Attain Select™ II 6248DEL Delivery Catheter System are external communicating devices with limited exposure (<24 hours) to circulating blood.
Sterilization Validation
The Attain Select™ II 6248DEL Delivery Catheter System will be sterilized using a validated Ethylene Oxide (EtO) sterilization process.
Conclusion
Through the data and information presented, Medtronic Ireland considers the Attain Select™ II 6248DEL Delivery Catheter System to be substantially equivalent to legally marketed predicate devices.
{2}------------------------------------------------
Image /page/2/Picture/2 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized eagle with three heads facing to the right. The text "DEPARTMENT OF HEALTH AND HUMAN SERVICES, USA" is arranged in a circular pattern around the eagle.
JUN 2 7 2006
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Medtronic Ireland c/o Ms. Clare Higgins Regulatory Affairs Co-ordinator Parkmore Business Park West Galway, IRELAND
Re: K053431
Attain Select II 6248DEL Delivery Catheter System Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous Catheter Regulatory Class: Class II (Two) Product Code: DQY Dated: February 13, 2006 Received: February 15, 2006
Dear Ms. Higgins:
This letter corrects our substantially equivalent letter of March 16, 2006.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may. therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA). it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801): good manufacturing practice requirements as set forth in the quality
{3}------------------------------------------------
Page 2 - Ms. Clare Higgins
systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Bhemimma fir
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
{4}------------------------------------------------
INDICATIONS FOR USE
510(k) Number (if known):_____________________________________________________________________________________________________________________________________________________
Device Name: Attain Select™ II 6248DEL Delivery Catheter System
Indications For Use: The Medtronic Attain Select™ II model 6248DEL delivery catheter system is indicated for the delivery of contrast medium i and transvenous devices to the coronary sinus and left heart venous anatomy.
The delivery catheter system is indicated for use with outer catheters.
X Prescription Use (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
B. Kimmerman
(Division Sign-Off)
(Division Sign-OM)
Division of Cardiovascular Devices
510(k) Number K053431
Medtronic Ireland Attain Select™ II 6248DEL Delivery Catheter System Traditional 510(k)
§ 870.1250 Percutaneous catheter.
(a)
Identification. A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.(b)
Classification. Class II (performance standards).